Molecular markers of osteoarthritis;Molekulární markery osteoartrózy

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

Volumn 72, Issue 3, 2005, Pages 191-196

  Šenolt, Ladislav ^a   Pavelka, K ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Alteration of joint tissue metabolism; Molecular markers; Osteoarthritis; Radiological findings

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN; DEOXYPYRIDINOLINE; GLYCOPROTEIN GP 39; HYALURONIC ACID; MATRIX METALLOPROTEINASE; MOLECULAR MARKER; OSTEOCALCIN; PENTOSIDINE; PYRIDINOLINE; SIALOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; ARTICULAR CARTILAGE; BONE RADIOGRAPHY; BONE TURNOVER; CARTILAGE DEGENERATION; CLINICAL FEATURE; DISEASE COURSE; EARLY DIAGNOSIS; HIGH RISK PATIENT; HUMAN; MEDICAL ASSESSMENT; OSTEOARTHRITIS; PATIENT MONITORING; PREDICTION; SUTURING METHOD; SYNOVITIS; TISSUE METABOLISM;

BIOLOGICAL MARKERS; HUMANS; INFLAMMATION MEDIATORS; OSTEOARTHRITIS;

EID: 22144437046     PISSN: 00015415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ALTMAN, R., ASCH, E., BLOCH, D. ET AL. Development of criteria for the calssification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthr. and Rheum., 29: 1039-1049, 1986.
2. ATTUR, M. G., DAVE, M., AKAMATSU, M., KATOH, M., AMIN, A. R.: Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage, 10: 1-4, 2002.
3. BETTICA, P., CLINE, G., HART, D. J., MEYER, J., SPECTOR, T. D.: Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthr. and Rheum., 46: 3178-3184, 2002.
4. BOBACZ, K., MAIER, R., FIALKA, C. ET AL.: Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation? Osteoarthritis Cartilage, 11: 665-672, 2003.
5. BRUYERE, O., COLLETTE, J. H., ETHGEN, O. ET AL.: Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J. Rheumatol., 30: 1043-1050, 2003.
6. CONROZIER, T., CARLIER, M. C., MATHIEU, P. ET AL.: Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann. Rheum. Dis., 59: 828-831, 2000.
7. CONROZIER, T., SAXNE, T., FAN, C. S., MATHIEU, P., TRON, A. M., HEINEGARD, D., VIGNON, E.: Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann. Rheum. Dis., 57: 527-532, 1998.
8. CRNKIC, M., MANSSON, B., LARSSON, L., GEBOREK, P., HEINEGARD, D., SAXNE, T.: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res. Ther., 5: R181-185, 2003.
9. DEGROOT, J., VERZIJL, N., WENTING-VAN, WIJK, M. J. ET AL.: Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum., 50: 1207-1215, 2004.
10. FAWTHROP, F., YAQUB, R., BELCHER, C., BAYLISS, M., LEDINGHAM, J., DOHERTY, M:. Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis. Ann. Rheum. Dis., 56: 119-122, 1997.
11. FOREJTOVÁ, Š., PAVELKA, K., GATTEROVÁ, J., ŠENOLT, L.: Rychle progredující osteoartróza a metody hodnocení progrese osteoartrózy. Čes. Revmatol., 10: 11-18, 2002.
12. GARNERO, P., AYRAL, X., ROUSSEAU, J. C., CHRISTGAU, S., SANDELL, L. J., DOUGADOS, M., DELMAS, P. D.: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthr. and Rheum., 46: 2613-2624, 2002.
13. GARNERO, P., CONROZIER, T., CHRISTGAU, S., MATHIEU, P., DELMAS, P. D., VIGNON, E.: Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann. Rheum. Dis., 62: 939-943, 2003.
14. GARNERO, P., DELMAS, P. D.: Biomarkers in osteoarthritis. Curr. Opin. Rheumatol., 15: 641-646, 2003.
15. GARNERO, P., GINEYTS, E., CHRISTGAU, S., FINCK, B., DELMAS, P. D.: Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthr. and Rheum., 46: 21-30, 2002.
16. GARNERO, P., LANDEWE, R., BOERS, M. ET AL.: Association of baseline levels of markers of bone and cartilage degradationwith long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthr. and Rheum., 46: 2847-2856, 2002.
17. GARNERO, P., PIPERNO, M., GINEYTS, E., CHRISTGAU, S., DELMAS, P. D., VIGNON, E.: Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann. Rheum. Dis., 60: 619-626, 2001.
18. GRAVERAND, M. P., TRON, A. M., ICHOU, M. ET AL.: Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis. Brit. J. Rheumatol., 35: 1091-1095, 1996.
19. CHEVALIER, X., CONROZIER, T., GEHRMANN, M. ET AL.: Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis. Osteoarthritis Cartilage, 9: 300-307, 2001.
20. CHRISTGAU, S., HENROTIN, Y., TANKO, L. B. ET AL.: Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin. Exp. Rheumatol., 22: 36-42, 2004.
21. JOHANSEN, J. S., HVOLRIS, J., HANSEN, M., BACKER, V., LORENZEN, I., PRICE, P. A.: Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Brit. J. Rheumatol., 35: 553-559, 1996.
22. JUNG, M., CHRISTGAU, S., LUKOSCHEK, M., HENRIKSEN, D., RICHTER, W.: Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology, 71: 70-76, 2004.
23. LANDEWE, R., GEUSENS, P., BOERS, M. ET AL.: Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthr. and Rheum., 50: 1390-1399, 2004.
24. LAWRENCE, R. C., HELMICK, G. G., ARNETT, D. F. ET AL.: Estimates of the prevalence of arthritis and selected musculosceletal disorders in the United States. Arthr. and Rheum., 41: 778-788, 1998.
25. MANICOURT, D. H., POILVACHE, P., VAN EGEREN, A., DEVOGELAER, J. P., LENZ, M. E., THONAR, E. J.: Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthr. and Rheum., 43: 281-288, 2000.
26. MARTEL-PELLETIER, J., MCCOLLUM, R., FUJIMOTO, N., OBATA, K., CLOUTIER, J. M., PELLETIER, J. P.: Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest., 70: 807-815, 1994.
27. MASSICOTTE, F., LAJEUNESSE, D., BENDERDOUR, M. ET AL.: Can altered production of interleukin-lbeta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage, 10: 491-500, 2002.
28. MASUHARA, K., NAKAI, T., YAMAGUCHI, K., YAMASAKI, S., SASAGURI, Y.: Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthr. and Rheum., 46: 2625-2631, 2002.
29. MYERS, S. L., O'CONNOR, B. L., BRANDT, K. D.: Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of "cartilage markers" in synovial fluid. J. Rheumatol., 23: 1744-1748, 1996.
30. NAITO, K., TAKAHASHI, M., KUSHIDA, K. ET AL.: Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford), 38: 510-515, 1999.
31. OLEJÁROVÁ, M., SEIDL, Z., VANĚČKOVÁ, M. ET AL.: Longitudinální sledování progrese MR obrazu kolenních kloubů u gonartrózy. Výsledky dvouleté studie. Čes. Revmatol., 4: 169-173, 2003.
32. OTTERNESS, I. G., SWINDELL, A., ZIMMERER, R. O., POOLE, A. R., IONESCU, M., WEINER, E.: An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis cartilage, 8: 180-185, 2000.
33. PAVELKA, K., FOREJTOVÁ, S., OLEJAROVÁ, M. ET AL.: Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage, 12: 277-283, 2004.
34. PAVELKA, K., GATTEROVÁ, J., OLEJAROVÁ, M., MACHACEK, S., GIACOVELLI, G., ROVATI, L. C.: Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch. Int. Med., 162: 2113-2123, 2002.
35. PETERSSON, I. F., BOEGARD, T., DAHLSTROM, J., SVENSSON, B., HEINEGARD, D., SAXNE, T.: Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis Cartilage, 6: 33-39, 1998.
36. ROVETTA, G., MONTEFORTE, P., GRIGNOLO, M. C., BRIGNONE, A., BUFFRINI, L.: Hematic levels of type I collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands. Int. J. Tissue React., 25: 25-28, 2003.
37. SALVATIERRA, J., ESCAMES, G., HERNANDEZ, P. ET AL.: Cartilage and serum levels of nitric oxide in patients with hip osteoarthritis. J. Rheumatol., 26: 2015-2017, 1999.
38. SAXNE, T., HEINEGARD, D.: Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Brit. J. Rheumatol., 31: 583-591, 1992.
39. SMITH, M. D., TRIANTAFILLOU, S., PARKER, A., YOUSSEF, P. P., COLEMAN, M.: Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J. Rheumatol., 24: 365-371, 1997.
40. STRAUSS, W. L., CAVE, A. J.: Pathology and posture of Neanderthal man. Quarterly reviews of Biology, 32: 348-363, 1957.
41. STURMER, T., BRENNER, H., KOENIG, W., GUNTHER, K. P.: Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann. Rheum. Dis., 63: 200-2005, 2004.
42. SUGIYAMA, S., ITOKAZU, M., SUZUKI, Y., SHIMIZU, K.: Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann. Rheum. Dis., 62: 27-32, 2003.
43. ŠENOLT, L., BRAUN, M., PAVELKA, K.: Konečné produkty pokročilé glykace u pacientů s osteoartrózou a revmatoidní artritidou a jejich potenciální úloha v patogenezi těchto onemocnění. Čes. Revmatol., 3: 146-156, 2003.
44. ŠENOLT, L., PAVELKA, K.: Oxid dusnatý (NO), intermediární produkty NO a jejich vliv na patogenezi osteoartrózy. Čes. Revmatol., 1: 42-50, 2003.
45. ŠENOLT, L., PAVELKA, K.: Význam subchondrální kosti v patogenezi osteoartrózy. Osteologický bulletin, 9: 54-58, 2004.
46. UEKI, Y., MIYAKE, S., TOMINAGA, Y., EGUCHI, K.: Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol., 23: 230-236, 1996.
47. VILÍM, V., OLEJÁROVÁ, M., MACHÁČEK, S., GATTEROVÁ, J., KRAUS, V. B., PAVELKA, K.: Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis cartilage, 10: 707-713, 2002.
48. VILÍM, V., VYTÁŠEK, R., OLEJÁROVÁ, M. ET AL.: Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis cartilage, 9: 612-618, 2001.
49. WOLLHEIM, F. A.: Bone sialoprotein-a new marker for subchondral bone. Osteoarthritis Cartilage, 7: 331-332, 1999.
50. WOLLHEIM, F. A.: Early stages of osteoarthritis: the search for sensitive predictors. Ann. Rheum. Dis., 62: 1031-1032, 2003.